Signal2026-06-30
ClinicalTrials.gov

[PHASE2] Evaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected Adults

Part of

HIV Testing And Treatment Outcomes

Open primary sourceSee the whole picture